scholarly journals MANAGING PLACENTA ACCRETA SPECTRUM IN LOW RESOURCE SETTING USING A NOVEL DISSECTION-FREE AORTA CLAMP: OPERATIVE TECHNIQUE

Author(s):  
Vakkanal Paily ◽  
Afshana Sidhik ◽  
Raji Raj ◽  
Ajithakumari Sudhamma ◽  
Joshy Joseph ◽  
...  

A novel over-the-peritoneum aorta clamp enabled a senior obstetrician, backed by a urologist, to manage 33 women with histopathology-confirmed Placenta Accreta spectrum, with no maternal mortality, relatively low incidence of blood transfusion and urological injuries in a limited resource setting. Easily applied by the obstetricians themselves, this clamp can be an effective and relatively safer alternative to intra-aortic balloon occlusion and aortic-cross clamping. We anticipate, obstetricians in low-resource settings can easily adapt our methods and contribute further prospective evidence.

Author(s):  
Nabih I. Elkhouly ◽  
Ayman E. Solyman ◽  
Mohamed E. Anter ◽  
Zakaria F. Sanad ◽  
Alaa N. El Ghazaly ◽  
...  

2020 ◽  
Vol 302 (6) ◽  
pp. 1553-1554 ◽  
Author(s):  
Shigeki Matsubara ◽  
Hironori Takahashi ◽  
Yuji Takei ◽  
Hiroyasu Nakamura ◽  
Takashi Yagisawa

2015 ◽  
Vol 24 (4) ◽  
pp. 329-334 ◽  
Author(s):  
L.A. Muñoz ◽  
G.J. Mendoza ◽  
M. Gomez ◽  
L.E. Reyes ◽  
J.J. Arevalo

2018 ◽  
Vol 1 ◽  
pp. 32 ◽  
Author(s):  
Rose McGready ◽  
Moo Kho Paw ◽  
Jacher Wiladphaingern ◽  
Aung Myat Min ◽  
Verena I. Carrara ◽  
...  

Background: Countries vary on the demarcation gestational age that distinguishes miscarriage and extreme preterm birth (PTB). This study provides a synopsis of the outcome of pregnancy between 22 to <28 weeks’ gestation from a low resource setting. Methods: A retrospective record review of a refugee and migrant population on the Thailand-Myanmar border with outcome between 22 to <28 weeks’ gestation, was conducted. Outcomes were classified as miscarriage: non-viability prior to 22 week’s gestation with expulsion of products between 22 to < 28 weeks’ gestation; or extreme PTB when the fetus was viable at ≥22 weeks and delivered between 22 to < 28 weeks’ gestation. Termination of pregnancy and gestational trophoblastic disease were excluded. Results: From 1995-2015, outcomes occurred between 22 to <28 weeks’ gestation in 0.9% (472/49,931) of pregnancies and 3.8% (18/472) met the exclusion criteria. Most included pregnancies (n=454) had ultrasound done 72.5% (n=329). Overall 43.6% (n=197) were miscarriage and 56.4% (n=257) extreme PTB. Miscarriage (late expulsion) between 22 to <28 weeks was observed with non-viability occurring at an estimated median gestation of 16 weeks. For cases with available data (n=252, 5 missing) the proportion of stillborn was 47.6% (n=120), liveborn 52.4% (n=132); and congenital abnormality 10.5% (24/228, 29 missing). Neonatal death was high 98.5% (128/131, 1 missing). Introduction of ultrasound was associated with a 2-times higher odds of classification of outcome as birth rather than miscarriage. Conclusion: In this low resource setting <1% of pregnancy outcomes occur in the 22 to <28 weeks’ gestation window; nearly half  were miscarriage; and neonatal mortality approached 100%.  In the scale-up to preventable newborns deaths, at least initially, greater benefits will be obtained by focusing on the greater number of viable newborns with a gestation of 28 weeks or more.


2007 ◽  
Vol 28 (12) ◽  
pp. 1337-1338 ◽  
Author(s):  
Coralith Garcia ◽  
David Iglesias ◽  
Angélica Terashima ◽  
Marco Canales ◽  
Eduardo Gotuzzo

In a limited-resource hospital in Lima, Peru, 23 (63.9%) of 36 healthcare workers developed pruritus and/or skin lesions after contact with a patient with classic scabies. Of these 23, a total of 5 healthcare workers had scabies confirmed by microscopy. Oral ivermectin was used to control the outbreak effectively.


2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Marika Toscano ◽  
Kam Szlachetka ◽  
Natalie Whaley ◽  
Loralei L. Thornburg

Abstract Background Point-of-care ultrasound (POC-US) is a diagnostic test conducted at the site of patient care with direct interpretation by the clinician, providing immediate results. POC-US for gynecologic application is not well characterized by current literature yet has the potential to increase access in limited resource settings. We compared the diagnostics of three POC-US devices for gynecologic (GYN) pathology and then performed evaluation of sensitivity and specificity of a single best POC-US device for intended use in a low resource setting. Methods This is prospective, pilot descriptive study of 60 subjects. In part 1, comparison of three POC-US devices was performed. Twenty subjects underwent POC-US with three test units [GE Vscan (Vscan), Sonosite Iviz (Iviz), Philips Lumify (Lumify)] followed by diagnostic ultrasound (Dx-US) for reference imaging. Image quality and correlation for devices was scored by blinded reviewers and quantitative measurements of GYN pathology were compared. In part 2, forty subjects underwent POC-US validation with the highest scoring device (Lumify) and Dx-US for reference imaging. Concordance of POC-US operator-interpreted diagnosis with reference imaging interpretation were assessed by Cohen’s unweighted kappa coefficient. Accuracy and agreement of POC-US were assessed by linear regression and Bland–Altman plot analysis. Sensitivity and specificity of POC-US for gynecologic pathologies were calculated. Results In aggregate qualitative measurements, Lumify and Iviz units performed superiorly to Vscan. There was no statistically significant difference in quantitative measurements between devices, but a trend towards lower mean error was seen for Lumify and Iviz as compared to Vscan. Lumify device had highest overall scoring and was selected for further testing. In validation comparison of Lumify to Dx-US, no statistically significant differences were found for measurements of endometrium, uterus, ovaries, adnexal pathology, or leiomyomata, (P < 0.02) with excellent agreement in operator-interpreted diagnosis (Kappa > 0.7). Sensitivity and specificity of detecting pathology was 80–100% with PPV and NPV 76–100%. Conclusion Among three POC-US devices, Lumify and Iviz devices show highest potential for successful application to clinical gynecologic ultrasound. Clinician-performed POC-US has high diagnostic accuracy, sensitivity, and specificity for basic GYN anatomy and pathology. POC-US is an acceptable and feasible diagnostic tool with potential for future application in a low resource setting to increase access to ultrasound.


Sign in / Sign up

Export Citation Format

Share Document